Predictability


Fluofarma High Content Screening technology enables large-scale analysis of compounds in their real cellular environment. Thus, in contrast to standard drug discovery methods, Fluofarma's HCS technology is both powerful and highly predictive.

Our technology enables:
Functional measuring: Assessment of molecular events in living cells
Multiplexing analysis: Measure of up to 5 parameters simultaneously in single cells


Fluofarma's proprietary technology affords a highly predictive method for identifying, selecting, characterizing and understanding any kinds of compounds and its effects.  

Download Platform.pdf

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the Journal of Cell Science.

    Read more [+]

  • SMi's Cell-Based Assays 2008

    Fluofarma will be attending SMi's Cell-Based Assays conference, in London from November 19th to 20th.

    Read more [+]

  • GDDI Forum 2009

    Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.

    Read more [+]

Career opportunities:
Fluofarma is searching for new talents, currently several positions are available:
- Research Associates
- Bioengineers
Read more [+]